Historical Stock Price
ETFs Holding ADMS »    ADMS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
11/18/2021 $8.18 $8.21 $8.17 $8.17 1.26M
11/19/2021 $8.17 $8.19 $8.15 $8.16 348.50K
11/22/2021 $8.16 $8.21 $8.15 $8.16 1.05M
11/23/2021 $8.24 $8.25 $8.18 $8.22 3.15M
11/24/2021 $8.22 $8.22 $8.22 $8.22 0
Adamas Pharmaceuticals focuses on a portfolio of therapies to reduce the burden of neurological diseases on patients, caregivers, and society. Co.'s portfolio includes: GOCOVRI® (amantadine) extended release capsules for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, and as adjunctive treatment for patients with Parkinson's disease taking levodopa/carbidopa experiencing reemergence or sudden return of stiffness, rigidity and tremors; and OSMOLEX ER® (amantadine) extended release tablets for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adult patients.
ADMS historical stock prices picture
Adamas Pharmaceuticals (ADMS) has the following price history information. Looking back at ADMS historical stock prices for the last five trading days, on November 18, 2021, ADMS opened at $8.18, traded as high as $8.21 and as low as $8.17, and closed at $8.17. Trading volume was a total of 1.26M shares. On November 19, 2021, ADMS opened at $8.17, traded as high as $8.19 and as low as $8.15, and closed at $8.16. Trading volume was a total of 348.50K shares. On November 22, 2021, ADMS opened at $8.16, traded as high as $8.21 and as low as $8.15, and closed at $8.16. Trading volume was a total of 1.05M shares. On November 23, 2021, ADMS opened at $8.24, traded as high as $8.25 and as low as $8.18, and closed at $8.22. Trading volume was a total of 3.15M shares. On November 24, 2021, ADMS opened at $8.22, traded as high as $8.22 and as low as $8.22, and closed at $8.22. Trading volume was a total of 0 shares.

ADMS Historical Stock Prices By Date:

ADMS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamas Pharmaceuticals shares, starting with a $10,000 purchase of ADMS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/11/2014
End date: 11/24/2021
Start price/share: $13.00
End price/share: $8.22
Dividends collected/share: $0.00
Total return: -36.77%
Average Annual Total Return: -5.83%
Starting investment: $10,000.00
Ending investment: $6,324.42
Years: 7.63
Date Close
11/18/2021$8.17
11/19/2021$8.16
11/22/2021$8.16
11/23/2021$8.22
11/24/2021$8.22
ADMS is categorized under the Healthcare sector; below are some other companies in the same sector:

ADPT Historical Stock Prices
ADRO Historical Stock Prices
ADUS Historical Stock Prices
ADVM Historical Stock Prices
ADXS Historical Stock Prices
AEGR Historical Stock Prices
AEMD Historical Stock Prices
AERI Historical Stock Prices
AEZS Historical Stock Prices
AFAM Historical Stock Prices

Also explore: ADMS shares outstanding history

Email EnvelopeFree ADMS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ADMS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.